CStone Pharmaceuticals Share Price Deutsche Boerse AG
Stocks
PH4
KYG2588M1006
Pharmaceuticals
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5022 EUR | +4.04% |
|
-6.79% | -11.89% |
| Market Cap | 6.46B 954M 836M 773M 711M 1.34B 91.99B 1.36B 9.24B 3.62B 45.01B 3.58B 3.5B 155B | P/E 2026 * |
-303x | P/E 2027 * | 6.03x |
|---|---|---|---|---|---|
| Enterprise Value | 5.93B 876M 768M 710M 653M 1.23B 84.47B 1.25B 8.49B 3.33B 41.33B 3.29B 3.22B 142B | EV / Sales 2026 * |
12.4x | EV / Sales 2027 * | 1.67x |
| Free-Float |
77.71% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: CStone Pharmaceuticals
| 1 day | +4.04% | ||
| 1 week | -6.79% | ||
| Current month | -6.58% | ||
| 1 month | -0.55% | ||
| 3 months | -54.96% | ||
| 6 months | -14.15% | ||
| Current year | -11.89% |
| 1 week | 0.48 |  | 0.57 |
| 1 month | 0.48 | | 0.6 |
| Current year | 0.45 | | 1.12 |
| 1 year | 0.45 | | 1.35 |
| 3 years | 0.09 | | 1.35 |
| 5 years | 0.09 | | 1.81 |
| 10 years | 0.09 | | 1.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jian Xin Yang
CEO | Chief Executive Officer | 62 | 24/08/2022 |
Wei Cong Ni
DFI | Director of Finance/CFO | - | 17/01/2023 |
Ying Hua Zhang
COO | Chief Operating Officer | 46 | 31/07/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Wei Li
CHM | Chairman | 55 | - |
Jian Xin Yang
BRD | Director/Board Member | 62 | 24/08/2022 |
Edward Hu
BRD | Director/Board Member | 63 | 08/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.04% | -6.79% | - | - | 923M | |
| +0.64% | +2.55% | +24.65% | -5.95% | 68.85B | |
| -0.54% | +1.02% | +37.33% | +189.96% | 52.13B | |
| -3.65% | +34.50% | +34.50% | +34.50% | 43.46B | |
| -0.58% | -0.23% | -52.36% | -53.82% | 41.24B | |
| -1.50% | -2.97% | +65.33% | -26.16% | 30.41B | |
| -0.62% | -8.30% | +98.42% | -50.75% | 24.53B | |
| -1.38% | +1.29% | +71.71% | +80.75% | 23.42B | |
| +3.99% | +3.12% | +3.87% | +200.81% | 19.75B | |
| +0.26% | +0.39% | +72.12% | +126.52% | 16.57B | |
| Average | +0.12% | -1.02% | +39.51% | +55.10% | 35.6B | |
| Weighted average by Cap. | -0.50% | -0.46% | +32.26% | +45.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 479M 70.78M 62.04M 57.35M 52.74M 99.52M 6.83B 101M 686M 269M 3.34B 266M 260M 11.51B | 1.71B 253M 222M 205M 189M 356M 24.4B 361M 2.45B 961M 11.94B 950M 929M 41.13B |
| Net income | -243M -35.92M -31.48M -29.1M -26.76M -50.49M -3.46B -51.3M -348M -136M -1.69B -135M -132M -5.84B | 687M 102M 88.98M 82.25M 75.65M 143M 9.79B 145M 983M 386M 4.79B 381M 373M 16.5B |
| Net Debt | -528M -78M -68.37M -63.2M -58.12M -110M -7.52B -111M -756M -296M -3.68B -293M -287M -12.68B | -3.6B -532M -466M -431M -396M -748M -51.31B -760M -5.15B -2.02B -25.11B -2B -1.95B -86.5B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | €0.5022 | +4.04% | 0 |
| 17/07/26 | €0.4827 | -14.84% | 0 |
| 16/07/26 | €0.5668 | +0.89% | 0 |
| 15/07/26 | €0.5618 | +6.28% | 0 |
| 14/07/26 | €0.5286 | -1.89% | 0 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2616 Stock
- PH4 Stock
Select your edition
All financial news and data tailored to specific country editions
